We fight to improve the lives
of everyone affected by epilepsy

Drugwatch

Gabitril (tiagabine) out of stock in the UK

20 Aug 2019

Update: 19 August 2019
We have heard from Teva, the makers of Gabitril, that Gabitril will not be back in stock before the end of October. This further delay is caused by a problem with part of the manufacturing process. This is a Europe-wide issue.

Teva have also advised us that the same manufacturing problem may mean that Gabitril 10mg could experience a disruption in supply in early 2020.

Epanutin oral suspension shortage in the UK

13 Aug 2019

Updated story 13 August 2019:

Epanutin oral suspension is still out of stock. It was hoped that it would be back in stock by now. Pfizer, the makers of Epanutin, are not yet able to provide a date when it is expected to be back in stock. If you have any concerns about this continuing shortage of Epanutin oral suspension, speak to your GP, epilepsy nurse or epilepsy specialist.

Original story 7 June 2019:

Milpharm topiramate stock in the UK

7 Aug 2019

Update: 7 August 2019

Milpharm topiramate 25mg tablets have been out of stock. Milpharm now has them back in stock but needs to put the tablets through technical checks. The tablets should be available from pharmacists around the week beginning 26 August 2019.

All other strengths of Milpharm topiramate tablets are in stock.

Original story: 3 April 2019

Milpharm topiramate tablets are temporarily out of stock in the 50mg and 100mg strengths. Milpharm expects to have both strengths back in stock in the first week of May.

Frisium and Epilim supply affected by delivery delay in the UK

1 Aug 2019

There has been a temporary disruption to the supply of some medicines made by Sanofi, including Epilim and Frisium. Sanofi has sent us the following statement:

“Following the implementation of a new IT system by our third-party logistics provider, Kuehne & Nagel, at their warehouse in Chapeltown, pharmacies in the UK will have experienced delays in the delivery of some Sanofi medicines.

Deliveries of Sanofi medicines have now been increased significantly and we expect stock levels at our wholesale suppliers to be back to normal by 2 August 2019.

Mylan oxcarbazepine stock in the UK

1 Aug 2019

Mylan is out of stock of its version of oxcarbazepine 300mg and 600mg tablets.

The 300mg tablets are due back in stock in the week beginning 12 August 2019.

The 600mg tablets are due back in stock in the week beginning 13 September 2019.

The 150mg tablets are currently in stock.

Other manufacturers’ versions of oxcarbazepine are available. If you have any concerns about taking a different version of your medicine, speak to your GP, epilepsy nurse or epilepsy specialist.

Epilim Chronosphere modified release granules

12 Jul 2019

Epilim Chronosphere modified release 1,000mg granules are temporarily out of stock in the UK. This is due to an increase in demand. Sanofi expects to have them back in stock by mid-August 2019.

All other strengths of Epilim Chronosphere modified release granules are available. Other formulations of Epilim (sodium valproate) are also in stock.

Sanofi has advised that anyone with concerns about Epilim stock levels should speak to their pharmacist, who will be able to check stock levels in their area.

Frisium temporary shortage in the UK

1 Jul 2019

Sanofi have told us that their supply of Frisium (clobazam) 10mg tablets has been significantly reduced over the past 2 weeks. This is due to a temporary manufacturing disruption, coupled with changes to packaging.

Sanofi say they are taking steps to speed up the delivery of Frisium to their suppliers, and expect to have stock back to normal levels by 5 July 2019.

Pages